BenevolentAI
regulatory validation a covid treatment now fully approved for use by the novel our technology and work a previously unknown antiviral mechanism published research in rapid the benevolent platform empowered scientists to rapidly formulate a hypothesis in just hours effective shown to reduce mortality from covid in controlled trials barrier trial showed reduces mortality by in patients and by in ventilated or patients led to equity investment from approved the use of to treat covid in may after granting emergency use for in combination with in identified lancet | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
15 of 46
Similar slides by BenevolentAI
See diffirences between slides (animation)
Investor Conference
November 2022
regulatory validation a covid treatment now fully approved for use by the novel our technology and work a previously unknown antiviral mechanism published research in rapid the benevolent platform empowered scientists to rapidly formulate a hypothesis in just hours effective shown to reduce mortality from covid in controlled trials barrier trial showed reduces mortality by in patients and by in ventilated or patients led to equity investment from approved the use of to treat covid in may after granting emergency use for in combination with in identified lancet | BenevolentAI
Investor Day
September 2022
regulatory validation a covid treatment now fully approved for use by the novel our technology and work a previously unknown antiviral mechanism published research in rapid the benevolent platform empowered scientists to rapidly formulate a hypothesis in just hours effective shown to reduce mortality from covid in controlled trials barrier trial showed reduces mortality by in patients and by in ventilated or patients led to equity investment from approved the use of to treat covid in may after granting emergency use for in combination with in identified lancet | BenevolentAI
Related slides by other companies
Dare Bioscience
Investor Presentation
February 2023
dare | Dare Bioscience
Dare Bioscience
Investor Presentation
February 2023
advancing products women want the portfolio snapshot | Dare Bioscience
Dare Bioscience
Investor Presentation
February 2023
approved phosphate vaginal gel | Dare Bioscience
Certara
Investor Day
December 2021
increasing regulatory adoption | Certara
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io